Literature DB >> 16762915

The ferrous-dioxygen intermediate in human cytochrome P450 3A4. Substrate dependence of formation and decay kinetics.

Ilia G Denisov1, Yelena V Grinkova, Bradley J Baas, Stephen G Sligar.   

Abstract

The oxy-ferrous complex is the first of three branching intermediates in the catalytic cycle of cytochrome P450, in which the total efficiency of substrate turnover is curtailed by the side reaction of autoxidation. For human membrane-bound cytochromes P450, the oxy complex is believed to be the primary source of cytotoxic superoxide and peroxide, although information on the properties and stability of this intermediate is lacking. Here we document stopped-flow spectroscopic studies of the formation and decay of the oxy-ferrous complex in the most abundant human cytochrome P450 (CYP3A4) as a function of temperature in the substrate-free and substrate-bound form. CYP3A4 solubilized in purified monomeric form in nanoscale POPC bilayers is functionally and kinetically homogeneous. In substrate-free CYP3A4, the oxy complex is extremely unstable with a half-life of approximately 30 ms at 5 degrees C. Saturation with testosterone or bromocriptine stabilizes the oxy-ferrous intermediate. Comparison of the autoxidation rates with the available data on CYP3A4 turnover kinetics suggests that the oxy complex may be an important route for uncoupling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762915     DOI: 10.1074/jbc.M605511200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Redox potential control by drug binding to cytochrome P450 3A4.

Authors:  Aditi Das; Yelena V Grinkova; Stephen G Sligar
Journal:  J Am Chem Soc       Date:  2007-10-19       Impact factor: 15.419

Review 2.  Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

Authors:  Dmitri R Davydov; James R Halpert
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

3.  Cytochrome b5 enhances androgen synthesis by rapidly reducing the CYP17A1 oxy-complex in the lyase step.

Authors:  Ruchia Duggal; Ilia G Denisov; Stephen G Sligar
Journal:  FEBS Lett       Date:  2018-06-21       Impact factor: 4.124

4.  The ferrous-oxy complex of human aromatase.

Authors:  Yelena V Grinkova; Ilia G Denisov; Michael R Waterman; Miharu Arase; Norio Kagawa; Stephen G Sligar
Journal:  Biochem Biophys Res Commun       Date:  2008-05-13       Impact factor: 3.575

5.  Mixing apples and oranges: Analysis of heterotropic cooperativity in cytochrome P450 3A4.

Authors:  Daniel J Frank; Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2009-06-26       Impact factor: 4.013

6.  Correction to "Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213".

Authors:  Ilia G Denisov; Yelena V Grinkova; Prithviraj Nandigrami; Mrinal Shekhar; Emad Tajkhorshid; Stephen G Sligar
Journal:  Biochemistry       Date:  2019-06-06       Impact factor: 3.162

Review 7.  Spectroscopic studies of the cytochrome P450 reaction mechanisms.

Authors:  Piotr J Mak; Ilia G Denisov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-06-28       Impact factor: 3.036

8.  Magic-angle spinning solid-state NMR spectroscopy of nanodisc-embedded human CYP3A4.

Authors:  Aleksandra Z Kijac; Ying Li; Stephen G Sligar; Chad M Rienstra
Journal:  Biochemistry       Date:  2007-11-07       Impact factor: 3.162

9.  Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs.

Authors:  T K Ritchie; Y V Grinkova; T H Bayburt; I G Denisov; J K Zolnerciks; W M Atkins; S G Sligar
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 10.  Membrane protein assembly into Nanodiscs.

Authors:  Timothy H Bayburt; Stephen G Sligar
Journal:  FEBS Lett       Date:  2009-10-16       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.